| Ms Denise Canonaco, MS CCC-SLP | |
|
1829 Denver West Dr # 27, Golden, CO 80401-3120 | |
| (303) 982-6500 | |
| Not Available |
| Full Name | Ms Denise Canonaco |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1829 Denver West Dr # 27, Golden, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053189696 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 24431668 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Denise Canonaco, MS CCC-SLP 1829 Denver West Dr # 27, Golden, CO 80401-3120 Ph: (303) 982-6500 | Ms Denise Canonaco, MS CCC-SLP 1829 Denver West Dr # 27, Golden, CO 80401-3120 Ph: (303) 982-6500 |
News Archive
Infection preventionists and healthcare epidemiologists play key roles in promoting effective antimicrobial stewardship in collaboration with other health professionals, according to a joint position paper published today by the Association for Professionals in Infection Control and Epidemiology (APIC) and the Society for Healthcare Epidemiology of America (SHEA) in their respective peer-review journals, the American Journal of Infection Control and Infection Control and Hospital Epidemiology.
Medtronic, Inc. today released new STOP AF clinical trial data showing the number of paroxysmal atrial fibrillation patients reporting AF symptoms declined by 80 percent after treatment with the Arctic Front Cardiac CryoAblation Catheter System.
House Energy and Commerce Committee Chair John Dingell (D-Mich.) and Oversight and Investigations Subcommittee Chair Bart Stupak (D-Mich.) in a recent letter warned four pharmaceutical companies to end the use of "misleading and deceptive" direct-to-consumer advertisements for medications, CQ HealthBeat reports.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that a third multi-center Phase 3 clinical study of Lymphoseek (NEO3-09) has received investigational review board approval and begun enrollment of subjects diagnosed with breast cancer or melanoma.
› Verified 1 days ago
Suzanne Sharpe, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1829 Denver West Dr Bldg 27, Golden, CO 80401 Phone: 303-982-6682 | |
Lara Harshfield Slp, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1119 11th St, Golden, CO 80401 Phone: 303-328-7805 | |
Lindsay B Koup, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1829 Denver West Dr # 27, Golden, CO 80401 Phone: 303-982-6500 | |
Lara Kristen Harshfield, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1829 Denver West Dr Bldg 27, Golden, CO 80401 Phone: 303-328-7805 | |
Cindy Dipaola, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1829 Denver West Dr Bldg 27, Golden, CO 80401 Phone: 303-982-1771 | |
Paula Jean Glenn, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1829 Denver West Dr, Golden, CO 80401 Phone: 303-982-6500 |